| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-12-3614 |
| P698 | PubMed publication ID | 23633456 |
| P50 | author | Robyn Ward | Q30503543 |
| Oliver Sieber | Q38319243 | ||
| Peter L Molloy | Q41534437 | ||
| Nicholas J. Hawkins | Q43280190 | ||
| Robert N Jorissen | Q51552627 | ||
| Peter Gibbs | Q51552633 | ||
| Jayesh Desai | Q56580375 | ||
| P2093 | author name string | Shan Li | |
| James Moore | |||
| Robert L Strausberg | |||
| Qi Zhao | |||
| Barbara A Leggett | |||
| Lara Lipton | |||
| Dana Busam | |||
| Vicki Whitehall | |||
| Anuratha Sakthianandeswaren | |||
| Michael Christie | |||
| Dmitri Mouradov | |||
| Ian T Jones | |||
| Stephen McLaughlin | |||
| Zheng-Zhou Xu | |||
| Andrew R Ruszkiewicz | |||
| Cary Tsui | |||
| Fiona L Day | |||
| Jeannie Tie | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 3285-3296 | |
| P577 | publication date | 2013-04-30 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer. | |
| P478 | volume | 19 |
| Q37161304 | AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants. |
| Q33732199 | Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review |
| Q97525750 | Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance |
| Q55492494 | Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway. |
| Q40198390 | Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer. |
| Q64123101 | Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis |
| Q39754979 | Clinicopathogenomic analysis of mismatch repair proficient colorectal adenocarcinoma uncovers novel prognostic subgroups with differing patterns of genetic evolution. |
| Q38255029 | Colorectal serrated pathway cancers and precursors |
| Q35198335 | Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer |
| Q92256962 | Current Update of Laboratory Molecular Diagnostics Advancement in Management of Colorectal Cancer (CRC) |
| Q27011884 | Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology |
| Q47763091 | EGFR pathway subgroups in Chilean colorectal cancer patients, detected by mutational and expression profiles, associated to different clinicopathological features |
| Q35067570 | Effectors of epidermal growth factor receptor pathway: the genetic profiling ofKRAS, BRAF, PIK3CA, NRAS mutations in colorectal cancer characteristics and personalized medicine |
| Q90225483 | Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of POLD1 and MLH1 |
| Q52660179 | Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway. |
| Q37243493 | Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes |
| Q38182985 | Functions and Regulation of the PTEN Gene in Colorectal Cancer |
| Q50727753 | GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival. |
| Q37537926 | Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy. |
| Q39967039 | Genotyping of colorectal cancer for cancer precision medicine: Results from the IPH Center for Molecular Pathology |
| Q92876951 | High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer |
| Q60939319 | How the V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications |
| Q92856179 | Immunological nomograms predicting prognosis and guiding adjuvant chemotherapy in stage II colorectal cancer |
| Q36551145 | Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation |
| Q37619856 | Important molecular genetic markers of colorectal cancer. |
| Q37080378 | In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity |
| Q38204286 | Insight into mucinous colorectal carcinoma: clues from etiology. |
| Q38473480 | Integrating biomarkers in colorectal cancer trials in the West and China |
| Q37282490 | Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases |
| Q92710353 | MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activity |
| Q59329900 | Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study |
| Q26785725 | Molecular phenotypes of colorectal cancer and potential clinical applications |
| Q36678527 | Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin |
| Q48084362 | Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers |
| Q50097873 | Mutations of key driver genes in colorectal cancer progression and metastasis |
| Q99415586 | Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark |
| Q33631628 | Network Analysis Reveals A Signaling Regulatory Loop in the PIK3CA-mutated Breast Cancer Predicting Survival Outcome |
| Q97070215 | Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas |
| Q35815544 | PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer |
| Q37612390 | PIK3CA in Colorectal Cancer |
| Q44448363 | PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma. |
| Q55518346 | PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer. |
| Q35236785 | PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer |
| Q54393310 | PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine. |
| Q36050773 | PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study |
| Q38363276 | Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies |
| Q37360360 | Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. |
| Q93198699 | Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer |
| Q30248900 | Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis |
| Q36413276 | Reduced rate of copy number aberrations in mucinous colorectal carcinoma |
| Q39067602 | Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1. |
| Q91847221 | Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer |
| Q48091765 | Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing. |
| Q38665334 | The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines |
| Q28083904 | The molecular background of mucinous carcinoma beyond MUC2 |
| Q37170486 | The prognostic value of Microsatellite Instability, KRAS, BRAF and PIK3CA mutations in stage II colon cancer patients |
| Q36341759 | Using Molecular Markers to Guide Therapy of Metastatic Colorectal Cancer |
| Q36081402 | Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer |
| Q37649634 | mTOR pathway in colorectal cancer: an update |
Search more.